South African Druggists Ltd. v Beecham Group Plc. (497/86) [1988] ZASCA 20 (22 March 1988)

South African Druggists Ltd. v Beecham Group Plc. (497/86) [1988] ZASCA 20 (22 March 1988)

The Supreme Court of Appeal held that the 1963 and 1969 patents were separate and distinct, with the 1969 patent covering a novel and inventive step—amoxycillin adapted for oral administration. The respondent was unable to exploit the 1969 patent for over three years due to opposition and regulatory delays, resulting in lost time and reduced remuneration. The extension of the 1963 patent did not compensate for this lost time, as it fell within the normal term of the 1969 patent and did not provide additional remuneration. The court affirmed that the proper test for adequacy of remuneration is the comparison between actual and potential remuneration, not public benefit or double...

Citation
[1988] ZASCA 20
Parties
Appellant: South African Druggists Limited; Respondent: Beecham Group p.l.c.
Court
Supreme Court of Appeal
Jurisdiction
South Africa
Judgment Date
22 March 1988
Case Number
497/86
Procedural Posture
Civil Appeal / Appeal From Full Bench of Transvaal Provincial Division
Outcome
Appeal dismissed with costs, including costs of two counsel.
Judges
Corbett, Hoexter, Smalberger, Nestadt, Nicholas
Legal Topics
Patent Extension, Adequate Remuneration, Lost Time, Novelty, Double Patenting
Intellectual Property Patent Extension Adequate Remuneration Lost Time Novelty Double Patenting

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 9 Party arguments 2
Sign in to unlock

Parties

South African Druggists Limited

Appellant

Beecham Group p.l.c.

Respondent

Procedural Posture

Civil Appeal / Appeal From Full Bench of Transvaal Provincial Division

Legal Issues

  1. 1 Whether the respondent derived adequate remuneration from the 1969 patent to justify an extension of its term.
  2. 2 Whether the extension of the 1969 patent constitutes impermissible double patenting.
  3. 3 Whether public benefit and compensation for utility are relevant to the adequacy of remuneration.

Ratio Decidendi

The Supreme Court of Appeal held that the 1963 and 1969 patents were separate and distinct, with the 1969 patent covering a novel and inventive step—amoxycillin adapted for oral administration. The respondent was unable to exploit the 1969 patent for over three years due to opposition and regulatory delays, resulting in lost time and reduced remuneration. The extension of the 1963 patent did not compensate for this lost time, as it fell within the normal term of the 1969 patent and did not provide additional remuneration. The court affirmed that the proper test for adequacy of remuneration is the comparison between actual and potential remuneration, not public benefit or double...

Court Disposition

Appeal dismissed with costs, including costs of two counsel.

Orders

  • The appeal is dismissed.
  • The appellant is ordered to pay the costs, including the costs of two counsel.